Antibacterial Haemostatic Gels Market Analysis

  • Report ID: 5907
  • Published Date: Nov 28, 2025
  • Report Format: PDF, PPT

Antibacterial Haemostatic Gels Market Segmentation:

Product Type Segment Analysis

The urinanalysis testing kits segment will grow the most by the forecast period and will hold almost 38% in the antibacterial haemostatic gels market because of modifying the efficiency, user-friendliness, and patient results. For instance, laboratories 'daily operations heavily rely on single-use plastics, and laboratory testing consumables are typically not susceptible to substitution. To ensure the safety and efficacy of testing protocols as well as the accuracy and reliability of data, laboratories are subject to stringent scientific and regulatory regulations. Life sciences research requires high-quality laboratory consumables, reagents, and validated standard processes. The life science sector has seen an unprecedented need for laboratory supplies related to COVID-19 laboratory work since the pandemic. With suppliers unable to keep up with demand, lab plastic consumables were being used at a faster rate than they were to run RT-PCR tests (consumables like plates and pipette tips). Therefore, this segment will hold immense importance in the transplant monitoring kits market.

End-Use Industry Segment Analysis

The hospital segment will have superior growth during the forecast period. It will hold around 50% of the revenue share of the antibacterial haemostatic gels market owing to the increasing extensive range of surgical techniques. More than 3 million deaths are caused by unsafe care each year and roughly 1 in every 10 patients suffer harm in healthcare. Up to 4 out of 100 people in low- to middle-income nations pass away in unsafe care. Global health is a key component of global surgery. The study and practice of global surgery aim to increase access to timely, affordable, and high-quality surgical care. It emphasizes strengthening horizontal health systems by addressing a variety of surgical care issues that improve patient outcomes, particularly in underserved populations.

Our in-depth analysis of the global antibacterial haemostatic gels market includes the following segments:

     Product Type

  • Urinalysis Testing Kits
  • Hematology Testing Kits
  • Blood Pressure Monitoring Devices
  • Blood Glucose Monitoring Devices

     Animal Type

  • Cats
  • Dogs
  • Horses

     End-User Industries

  • Homecare
  • Diagnostic Centres
  • Hospitals
  • Clinics

     Material

  • Fibrin
  • Gelatin

     Application

  • General Surgery
  • Dental Surgery
  • Veterinary Surgery
  • Cardiovascular Surgery
  • Orthopaedic Surgery

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of antibacterial haemostatic gels is assessed at USD 1.66 billion.

The global antibacterial haemostatic gels market size was valued at around USD 1.57 billion in 2025 and is projected to grow at a CAGR of more than 6.3%, reaching USD 2.89 billion revenue by 2035.

By 2035, North America is anticipated to command a 43% share in the antibacterial haemostatic gels market, attributed to the expanding advancement of healthcare infrastructure in the region.

Key players in the market include Pfizer Inc., DEXX Laboratories Inc., Medura, StopBleed, Zoetis Inc., Rapid-Seal, Coloplast Group, Gel-e-life sciences, PREVESTDenPro, Bio-Chem LLC, Smith & Nephew, Medtronic, B. Braun SE, 3M.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos